Baudax Bio, Inc.
BXRXQ · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $1 | $4 | $5 |
| + Debt | $8 | $9 | $7 | $7 |
| Enterprise Value | $8 | $7 | $4 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | -$4 |
| % Margin | – | – | – | -1,445.8% |
| EBITDA | -$5 | -$4 | -$5 | -$8 |
| % Margin | – | – | – | -2,442.3% |
| Net Income | -$2 | -$7 | $11 | -$9 |
| % Margin | – | – | – | -2,983.9% |
| EPS Diluted | -0.3 | -1.51 | 4.91 | -12.33 |
| % Growth | 80.1% | -130.8% | 139.8% | – |
| Operating Cash Flow | -$2 | -$3 | -$5 | -$4 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$3 | -$5 | -$4 |